Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05090800 · ClinicalTrials.gov registry record · Phase 2
Contrast Enhanced Ultrasound for Renal Obstruction
A Phase 2 study, sponsored by University of Michigan.
- Completed
- Registry status
- Phase 2
- Development phase
- 10
- Enrollment target
NCT05090800 is a Phase 2 study that has completed, run by University of Michigan. The registered enrollment target is 10 participants.
The verdict
NCT05090800, a Phase 2 study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 10 participants
- Enrollment target
Study Summary
This research is studying Definity ultrasound contrast agent, which is already approved by the Food and Drug Administration (FDA) for the ultrasound evaluation of the liver and heart. This research will investigate the ability to use ultrasound imaging with ultrasound contrast agents to evaluate kidney obstruction. Eligible participants that are enrolled will have two visits (one before and one after the planned surgery to relieve the kidney obstruction).
Interventions
- DRUG Definity contrast during ultrasound
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2021-12-03 |
| Est. Completion | 2025-09-23 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05090800
The ClinicalTrials.gov registry entry for NCT05090800 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Definity contrast during ultrasound is the first listed.
NCT05090800 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05090800 about?
NCT05090800 is a clinical study titled "Contrast Enhanced Ultrasound for Renal Obstruction". This research is studying Definity ultrasound contrast agent, which is already approved by the Food and Drug Administration (FDA) for the ultrasound evaluation of the liver and heart. This research will investigate the ability to use ultrasound imaging with ultrasound contrast agents to evaluate kid...
What is the current status of trial NCT05090800?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 10 participants. The study started on 2021-12-03. Estimated completion is 2025-09-23.
What interventions are being tested in trial NCT05090800?
The interventions under investigation include: Definity contrast during ultrasound (DRUG).
Who is sponsoring clinical trial NCT05090800?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.